Food Supplements Are Transforming Tuberculosis Survival In India
August 18, 2023
Long-Term Use of Certain Reflux Medications Associated With Higher Risk of Dementia
August 18, 2023

US Supreme Court Halts Purdue Pharma Deal That Shields Sackler Family From Lawsuits


The US supreme court has agreed to hear a challenge to the legality of OxyContin maker Purdue Pharma’s bankruptcy settlement that would shield its owners, the Sackler family, from lawsuits over their role in America’s opioid epidemic.


Purdue Pharma, an American drug company, is seen by many observers as having been largely responsible for the rise of the devastating opioid drug crisis in the United States. After introducing OxyContin, a powerful opioid painkiller, in 1996, the company proceeded to market it aggressively claiming that it was supposedly less addictive, less subject to abuse, and less likely to cause narcotic side effects. Seduced by Purdue Pharma’s deceptive marketing, American doctors subsequently wrote huge numbers of prescriptions for the drug.

Tragically, between 1999 and 2020, around 263,000 Americans are believed to have lost their lives as a result of overdoses related to prescription opioid drugs. Court filings suggest members of the notorious Sackler family, who own Purdue Pharma, directed efforts to mislead doctors and patients about the dangers of OxyContin.

Allowing the Sacklers to retain immunity from future opioid epidemic-related lawsuits would reportedly leave them with a collective fortune worth billions. Given their role in the crisis and the sheer number of deaths that have occurred, it is time for criminal charges to be brought against them.